Press releases, Investors Press releases, Investors17 April 202617 April 2026parDIAGNOS DIAGNOS-deposera-une-demande-dautorisation-de-pre-commercialisation-aupres-de-la-FDA-pour-son-systeme-CARA- Post navigation Previous PostDIAGNOS-Announces-Amendment-to-Convertible-Debentures-1 Next PostDIAGNOS-2025-Q3-MDA-1 Ressources connexe <img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="DIAGNOS Submits Modified and Updated Health Canada Licence Application for CARA System Platform" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 06 2026 DIAGNOS DIAGNOS Submits Modified and Updated Health Canada Licence Application for CARA System Platform Download PDF <img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-24-at-00.28.18.webp" alt="DIAGNOS lancera une étude d’essai clinique aux États-Unis à partir du 6 décembre 2021" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Resource center Investors 11 2021 DIAGNOS DIAGNOS lancera une étude d’essai clinique aux États Unis à partir du 6 décembre 2021 Download PDF <img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="DIAGNOS-Announces-Private-Placement-1" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 09 2025 DIAGNOS DIAGNOS Announces Private Placement 1 Download PDF
<img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="DIAGNOS Submits Modified and Updated Health Canada Licence Application for CARA System Platform" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 06 2026 DIAGNOS DIAGNOS Submits Modified and Updated Health Canada Licence Application for CARA System Platform Download PDF
<img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-24-at-00.28.18.webp" alt="DIAGNOS lancera une étude d’essai clinique aux États-Unis à partir du 6 décembre 2021" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Resource center Investors 11 2021 DIAGNOS DIAGNOS lancera une étude d’essai clinique aux États Unis à partir du 6 décembre 2021 Download PDF
<img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="DIAGNOS-Announces-Private-Placement-1" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 09 2025 DIAGNOS DIAGNOS Announces Private Placement 1 Download PDF